Key result
NETosis biomarkers correlate strongly with latent ICI myocarditis, outperforming hs-cTnT in preclinical and patient cohorts.
Why the study?
Although neutrophil extracellular trap formation (NETosis) is implicated in various autoimmune diseases, its contribution to immune checkpoint inhibitor-associated myocarditis (ICIAM) and its potential value for early detection and targeted treatment remained unexplored.
Does the NET/NETosis axis contribute to αPD1-induced latent and overt myocardial injury, and can NETosis biomarkers and MPO inhibition serve as diagnostic markers and therapeutic targets in ICI-associated myocarditis?
Observational (n=60)
Does the NET/NETosis axis contribute to αPD1-induced latent and overt myocardial injury, and can NETosis biomarkers and MPO inhibition serve as diagnostic markers and therapeutic targets in ICI-associated myocarditis?
This translational study identifies the NET/NETosis axis as a key driver and potential therapeutic target in immune checkpoint inhibitor-associated myocarditis, while showing that serum CitH3 and cfDNA may outperform hs-cTnT for early detection of latent myocardial injury.
Answers are grounded in this paper and cite their sources.
NETosis may represent a novel ICIAM target; hypothesis-generating in animal models and requires human validation before practice change.
Background Immune checkpoint inhibitors (ICIs) associated myocarditis (ICIAM) is a lethal complication caused mainly by cytotoxic CD8(+) T cells. Neutrophil extracellular traps (NETs) formation (NETosis), albeit an innate immune-mechanism, has also been implicated in various autoimmune diseases, yet its contribution to ICIAM remains unexplored. Objective This study aims to examine the role of NET/NETosis in the latent or overt ICIAM (OICIAM/LICIAM) induced by anti-programmed cell death protein-1 antibody (αPD1), and to explore the potential values of NET/NETosis in early detection and treatment targets of ICIAM. Methods The study first performed scRNA-seq of PBMCs from LICIAM patients and RNA-seq of myocardial tissues from melanoma-bearing mice with LICIAM and OICIAM to identify the differential expression genes (DEGs) and enrich potential pathway related to ICIAM. Then further assess the transcriptional and expression alterations of NET/NETosis axis in LICIAM mice, LICIAM mice treated with PF-1355 alone or in combination with PMA, with RT-qPCR, western blotting, and histopathological studies. Patients with LICIAM/OICIAM were recruited to essay serum biomarkers related to NET/NETosis and pyroptosis. Results Transcriptomic enrichment results from cancer patients and tumor-bearing mice with LICIAM identified the DEGs including CXCR1, GZMB, and CAPZB in humans, as well as Ly6g and Padi4 in mice, with pathway analyses consistently implicating neutrophils activation and NET/NETosis. Myocardial tissues from LICIAM mice demonstrated significantly increased fluorescence intensities of MPO and CitH3, accompanied by elevated mRNA levels of NETosis-related genes (Mpo, Ly6g, Padi4) and neutrophil-related chemokines (Cxcl2, Il17, Ifnγ) (all P<0.0001). Concurrently, the transcriptional and expressional level of NLRP3 inflammasome-pyroptosis pathway was activated. Treatment with the MPO inhibitor PF-1355 effectively reduced these changes, which could be totally reversed by PMA co-treatment, thereby confirming mechanistic involvement. In the clinical cohort with control (n=20), LICIAM (n=20), and OICIAM (n=20) groups, NETosis biomarkers (CitH3 and cfDNA) were strongly correlated with ICIAM patients, especially in LICIAM group (all R>0.80), while the conventional myocardial injury marker hs-cTnT showed only a moderate-to-strong association (all R≤0.75), suggesting that NETosis-related biomarkers may offer additional value to hs-cTnT for the early detection of LICIAM. Conclusion This study demonstrates that NET/NETosis contributes to ICIAM, particularly LICIAM, blocking NET/NETosis may be promising for ICIAM treatment, and assessing NETosis-related biomarkers may provide additional values to cardiac troponins for LICIAM detection. However, these findings based on animal experiments warrant further clinical verifications.central graphical abstract
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted an observational in Immune checkpoint inhibitors-associated myocarditis (ICIAM) (n=60). NETosis biomarkers (CitH3 and cfDNA) and MPO inhibitor PF-1355 vs. Control group and conventional myocardial injury marker hs-cTnT was evaluated on Correlation of NETosis biomarkers (CitH3 and cfDNA) with ICI-associated myocarditis (R >0.80, p=<0.0001). NETosis biomarkers (CitH3 and cfDNA) correlated strongly with latent ICI-associated myocarditis, and MPO inhibition reduced myocardial NETosis in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: